Grapefruit Usa Inc Asset Turnover Ratio (GPFT), as of third quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Grapefruit Usa Inc   (GPFT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Grapefruit Usa Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the third quarter 2022, Grapefruit Usa Inc 's asset turnover ratio sequentially decreased to 0.01 in the third quarter (Sep 30 2022), this is lower than usual.

Within sector 34 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2022 compared to the preceding quarter from 3249 to 3854.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GPFT Asset Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Asset Change -10.6 % -24.22 % -17.44 % -7.63 % 10.73 %
Y / Y Revenue Change -98.07 % -70.83 % -98.39 % -99.8 % -88.25 %
Asset Turnover Ratio (TTM) 0.01 0.07 0.08 0.19 0.53
GPFT's Total Ranking # 3854 # 3249 # 3815 # 4167 # 4178
Seq. Asset Change 13.57 % -13.24 % -2.15 % -7.27 % -3.74 %
Seq. Revenue Change -87.69 % 325.88 % 159.53 % -98.58 % 86.06 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 35
Healthcare Sector # 636
Overall Market # 3854

Asset Turnover Ratio Statistics
High Average Low
106.83 21.91 -16.2
(Sep 30 2020)   (Sep. 30, 2014)




GPFT Company Profile • Back to GPFT Efficiency Comparisons • Compare GPFT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Assets at quarter ending Sep 30 2022
Scynexis Inc   0.03 $ 4.164  Millions$ 119.826  Millions
Baudax Bio Inc   0.03 $ 1.360  Millions$ 40.109  Millions
Rosecliff Acquisition Corp I  0.03 $ 8.554  Millions$ 254.147  Millions
Bicycle Therapeutics Plc  0.03 $ 15.049  Millions$ 450.496  Millions
Foghorn Therapeutics Inc   0.03 $ 15.757  Millions$ 474.728  Millions
Inovio Pharmaceuticals Inc   0.03 $ 14.769  Millions$ 448.205  Millions
Vyant Bio Inc   0.03 $ 0.980  Millions$ 30.004  Millions
Rhythm Pharmaceuticals Inc   0.03 $ 9.911  Millions$ 320.409  Millions
Xbiotech Inc   0.03 $ 8.210  Millions$ 265.819  Millions
Tscan Therapeutics Inc   0.03 $ 5.180  Millions$ 168.545  Millions
Guided Therapeutics Inc   0.03 $ 0.073  Millions$ 2.400  Millions
Caribou Biosciences Inc   0.03 $ 12.718  Millions$ 427.136  Millions
Greenlight Biosciences Holdings Pbc  0.03 $ 4.172  Millions$ 145.050  Millions
Inhibrx Biosciences Inc   0.03 $ 4.774  Millions$ 167.424  Millions
Sonnet Biotherapeutics Holdings Inc   0.03 $ 0.350  Millions$ 12.277  Millions
Notable Labs Ltd   0.03 $ 1.426  Millions$ 50.449  Millions
Anavex Life Sciences Corp   0.03 $ 4.360  Millions$ 158.705  Millions
Prometheus Biosciences Inc   0.03 $ 7.193  Millions$ 264.397  Millions
Seer Inc   0.03 $ 13.954  Millions$ 520.684  Millions
Motus Gi Holdings Inc   0.03 $ 0.582  Millions$ 21.991  Millions
Talis Biomedical Corporation  0.03 $ 5.748  Millions$ 228.050  Millions
Igc Pharma Inc   0.02 $ 0.678  Millions$ 27.206  Millions
Tango Therapeutics Inc   0.02 $ 11.662  Millions$ 471.059  Millions
Insight Molecular Diagnostics Inc   0.02 $ 3.919  Millions$ 158.558  Millions
Lexaria Bioscience Corp   0.02 $ 0.255  Millions$ 10.413  Millions
Talphera Inc   0.02 $ 1.521  Millions$ 63.577  Millions
Oncternal Therapeutics Inc   0.02 $ 1.875  Millions$ 84.192  Millions
Wave Life Sciences Ltd   0.02 $ 4.175  Millions$ 192.299  Millions
2seventy Bio Inc   0.02 $ 16.062  Millions$ 776.937  Millions
Serina Therapeutics Inc   0.02 $ 0.053  Millions$ 2.614  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.